Zobrazeno 1 - 10 of 220 pro vyhledávání: '"F. Troalen"'
1
Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasia
Autor: P. Duvillard, Corinne Balleyguier, C. Lhomme, A. Rey, Anne Floquet, Karim Fizazi, Jean-Pierre Droz, Patricia Pautier, Philippe Morice, Caroline Even, P. Kerbrat, Alexandra Leary, Y. Tazi, Paule Augereau, F. Troalen
Publikováno v: European Journal of Cancer. 50:2082-2089
Background Patients with high-risk gestational trophoblastic neoplasia (GTN) need multi-agent chemotherapy to be cured. The most common regimen is etoposide (E), methotrexate (M) and actinomycin D (A), alternating weekly with cyclophosphamide (C) plu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7de79197bfb2c4cba5271d44a2347af6
https://doi.org/10.1016/j.ejca.2014.05.002
Zobrazit plný text záznamu
2
Prévalence de l'élévation du CA 15-3 lors de la rechute métastatique des cancers du sein: corrélation avec l'expression des récepteurs hormonaux et de Her2
Autor: M. Spielmann, R Conforti, F Troalen, T. Boulet, Y Bensouda, Fabrice Andre, Céline Bourgier, H Errihani, A Al-Ghuzlan, Suzette Delaloge
Publikováno v: Bulletin du Cancer. 96:923-928
CA15-3, a peptide derived from MUC-1, an hormonally-regulated protein, is the most widely used serum marker of breast cancer. CA15-3 level increases at the metastatic phase in 50-80% breast cancer patients. Although rise of CA15-3 precede symptoms of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1c94d3682a8c0215f8c42362e05afeb4
https://doi.org/10.1684/bdc.2009.0919
Zobrazit plný text záznamu
3
Specific detection of type II human chorionic gonadotropin beta subunit produced by trophoblastic and neoplastic cells
Autor: A. Nordor, F. Troalen, L. Aldaz-Carroll, Virginie Dangles-Marie, Thierry Fournier, Melanie Cocquebert, A.-M. Hersant, Alain Pecking, B. Guery, Dominique Bellet, Sophie Richon, D. Stevens, Jean Guibourdenche
Publikováno v: Clinica Chimica Acta
Clinica Chimica Acta, Elsevier, 2015, 444, pp.92-100. ⟨10.1016/j.cca.2015.02.009⟩
Clinica Chimica Acta, 2015, 444, pp.92-100. ⟨10.1016/j.cca.2015.02.009⟩
International audience; Background: The sequence of the beta-subunit of human chorionic gonadotropin (hCG beta varies depending on whether hCG beta is encoded by type I or type II genes. Type II genes are upregulated in trophoblast and cancer but hCG
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d12649ecc3c8970a81ab431cad221cbf
https://hal-cnrs.archives-ouvertes.fr/hal-03292710/document
Zobrazit plný text záznamu
4
Bcl-2 and CCND1/CDK4 expression levels predict the cellular effects of mTOR inhibitors in human ovarian carcinoma
Autor: Dominique Bellet, F. Troalen, Patricia Boya, Patrick Saulnier, Guido Kroemer, U. Zangemeister-Wittke, Jean Bénard, Eric Raymond, S. Hopkins-Donaldson, D. Aguirre, S. Faivre
Publikováno v: Apoptosis. 9:797-805
Molecular markers enabling the prediction of sensitivity/resistance to rapamycin may facilitate further clinical development of rapamycin and its derivatives as anticancer agents. In this study, several human ovarian cancer cell lines (IGROV1, OVCAR-
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f320432b176dc9423bb1e94e5e50717
https://doi.org/10.1023/b:appt.0000045781.46314.e2
Zobrazit plný text záznamu
5
Hypodermin A, a new inhibitor of human complement for the prevention of xenogeneic hyperacute rejection
Autor: Frédérique Taboit, N. Moiré, F. Troalen, Bernard Weill, Louis-Marie Houdebine, Didier Houssin, J. M. Regimbeau, Christiane Chéreau, Joe Attal, Benoît Malassagne, Filomena Conti, Frédéric Batteux, Yvon Calmus, C. Boulard
Publikováno v: Xenotransplantation. 10:267-277
Background: Hyperacute rejection (HAR) of discordant xenografts in the pig-to-human combination can be prevented using tranplants expressing transgenic molecules that inhibit human complement. Hypodermin A (HA), a serine esterase that degrades C3, wa
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::852b98bd5fb2c14f9244c9cb4874aecb
https://doi.org/10.1034/j.1399-3089.2003.02030.x
Zobrazit plný text záznamu
6
Specific immunostaining for CCP II, a novel calcitonin carboxyl terminal peptide encoded by the calcitonin/CGRP gene
Autor: N Segond, F Lasmoles, Ségolène Giscard-Dartevelle, J. Taboulet, P Ghillani, F Troalen
Publikováno v: Journal of Histochemistry & Cytochemistry. 41:1605-1610
Alternative splicing of the primary transcript of the CALC I gene in thyroid C-cells results predominantly in calcitonin (CT) mRNA (exons 1-4), whereas CGRP mRNA (exons 1, 2, 3, 5, and 6) is mainly produced in neuronal cells. The CT mRNA encodes for
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d6e9af3e02d80981f3b64fb85fdb569
https://doi.org/10.1177/41.11.7691931
Zobrazit plný text záznamu
7
Purification from Transformed Mouse Fibroblast of a Cell Growth Inhibitor which is an IGF-Binding Protein
Autor: C. Blat, L. Harel, J. Villaudy, F. Troalen, A. Golde, J. Delbé
Publikováno v: Growth Factors. 6:65-75
From medium conditioned by 3T3 cells, we had previously purified an inhibitory factor of Mr 45 kDa which we termed IDF45 (inhibitory diffusible factor). The protein was able to 100% inhibit stimulation induced in CEF by 1% calf serum and to reversibl
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb9fbbc42db8abce0021bfb50b8ba0fa
https://doi.org/10.3109/08977199209008872
Zobrazit plný text záznamu
8
[Prevalence of elevated serum CA 15-3 at time of metastatic relapse of breast cancer and correlation with hormone receptor status]
Autor: Y, Bensouda, F, André, T, Boulet, A, Al-Ghuzlan, R, Conforti, F, Troalen, C, Bourgier, H, Errihani, M, Spielmann, S, Delaloge
Publikováno v: Bulletin du cancer. 96(10)
CA15-3, a peptide derived from MUC-1, an hormonally-regulated protein, is the most widely used serum marker of breast cancer. CA15-3 level increases at the metastatic phase in 50-80% breast cancer patients. Although rise of CA15-3 precede symptoms of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ad87c2f31290a66232493e2575363bc0
https://pubmed.ncbi.nlm.nih.gov/19696005
Zobrazit plný text záznamu
10
Fetal-Maternal Hydrops Syndrome in Human Parvovirus Infection
Autor: Marianne Leruez, F. Morinet, F Brivet, F. Troalen, H. Fernandez, René Frydman, A. de Gayffier, P. Marchal, Yves Ville
Publikováno v: Fetal Diagnosis and Therapy. 10:204-206
A case of maternal generalized edema with hyponatremia, hypoosmolality and secondary hyperaldosteronism was associated with pseudomolar plasma human chorionic gonadotropin (hCG) concentrations in a case of fetal and placental hydrops due to parvoviru
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7671ed8c960b4e69182d45825d353757
https://doi.org/10.1159/000264237
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje